In various human cancers, like colon [12], prostate [13], and pancreatic [14], however, WASF3 is upregulated and, in the case of breast cancer, linked to increased invasive and metastatic cell potential through the regulation of epithelial-to-mesenchymal transition (EMT) [15,16]. This evidence concerns the gene WASF3 and breast carcinoma.